Which of the following needles should a phlebotomist use for collecting units of blood for donation?

Answer: A—The phlebotomist thoroughly disinfects the donor’s antecubital areas to prevent skin contaminant microorganisms (usually gram positive cocci such as Staphylococcus or Streptococcus) from entering the collected blood product after venipuncture.

From: Transfusion Medicine, Apheresis, and Hemostasis, 2018

Work Performance : Clinic-Based Assessment and Intervention

Terri M. Skirven OTR/L, CHT, in Rehabilitation of the Hand and Upper Extremity, 2021

Work Evaluation and job Simulation Case Example

In a case in which a phlebotomist sustained a cerebrovascular accident, her employer was not willing to allow her to return to work because she did not have any sensation in her dominant, affected hand distal to the wrist. The patient-employee insisted that she would be able to perform her job duties without the presence of sensation because she always has her eyes on the hand during the process of drawing blood (i.e., inserting the needle into the vein) and that she needed the sensation in her nondominant hand to palpate the vessels. With the patient’s permission, the employer was contacted and agreed to allow the phlebotomist’s job to be assessed to see if this was possible. During the job task assessment, two phlebotomists and a supervisor were interviewed and observed performing their work tasks. There was consensus that a phlebotomist does not use the sensation in the dominant hand and always visualizes the blood-drawing equipment during blood collection. The employer agreed that if the patient-employee could successfully demonstrate this during job simulation and then in live practice trials, she could return to her job. The phlebotomy department provided the therapist with needed tools (i.e., vacutainer and vials), and part of the patient’s outpatient therapy regimen included working with these tools in a job simulation using fruit and then a Simulaid (a mannequin arm specially made for this purpose) and then in actual trials of drawing blood from her therapists. The patient-employee was able to safely demonstrate competence in her work tasks at all levels and was allowed to return to her work.

Extraction Techniques and Applications: Biological/Medical and Environmental/Forensics

K. Lew, in Comprehensive Sampling and Sample Preparation, 2012

3.05.5.5 Gloves

Even though phlebotomists wash their hands before and after blood collection, gloves should still be worn, even when palplating for veins. Gloves offer protection from the transmission of infectious diseases between the phlebotomist and patient. If the skin integrity is damaged, a bandage worn under gloves offers increased exposure protection. Gloves are manufactured with different types of materials such as latex and nitrile. With the increasing prevalence of latex allergies, many institutions have switched to using nitrile-based gloves. If a phlebotomist cannot avoid wearing latex gloves, the option of wearing glove liners underneath is also possible. Gloves should never be reused nor disinfected with intentions for reuse.5

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9780123813732000685

Specimen Collection and Processing

Nader Rifai PhD, in Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 2018

Preliminary Steps.

In many institutions, at this point in the process, the patient should be asked about latex allergies. If latex allergy is present and if latex gloves or a latex tourniquet may be used, the phlebotomist should secure an alternative tourniquet and put on gloves that are latex free. Finally, for some specialized tests such as testing for genetic diseases, the performing laboratory may request a signed consent form from the patient or the use of a special requisition; these should be completed at the time of collection if not provided by the requesting physician.

Before collection of a specimen, the phlebotomist should dress in personal protective equipment (PPE), such as an impervious gown and gloves applied immediately before approaching the patient, and adhere to standard precautions against potentially infectious material; the goal is to limit the spread of infectious disease from one patient to another and to promote the safety of the phlebotomist. Because small children are often frightened of anyone in a white coat or gown, pediatric phlebotomists often dress in bright, cheerful colors, including colored PPE rather than standard white. Pediatric drawing stations are also often brightly colored with lots of distracters for the patient. If the phlebotomist must collect a specimen from a patient in isolation in a hospital, the phlebotomist must put on a clean gown and gloves and a face mask and goggles before entering the patient's room. The face mask limits the spread of potentially infectious droplets, and the goggles limit the possible entry of infectious material into the eye. The extent of the precautions required varies with the nature of the patient's illness and the institution's policies and bloodborne pathogen plan, to which a phlebotomist must adhere. For example, if airborne precautions are indicated, the phlebotomist must wear an N95 tuberculosis respirator in the United States.

If appropriate, the phlebotomist should verify that the patient has fasted, identify what medications are being taken or have been discontinued as required, and determine any other relevant information required.Chapter 5 describes in more detail the effects of diet and fluid intake and the recommended steps for patient preparation, including fasting, before phlebotomy. The patient should be comfortable, seated or supine (if sitting is not feasible), and should have been in this position for as long as possible before the specimen is drawn. The correct interpretation of certain tests (eg, aldosterone, renin, plasma metanephrines) requires that the patient is in a supine position for at least 30 minutes before venipuncture. (For details on the effects of position, refer toChapters 5 and63.) For an outpatient, it is generally recommended that patients be seated before completion of the identification process to maximize their relaxation. At no time should venipuncture be performed on a standing patient.

Infants and young children may need to be held in order to restrain them and prevent movement. Young children may be held sitting upright in a parent's lap with the parent helping to support and hold the patient and arm still2 (Fig. 4.1). Infants' blood is often drawn with the infant in a supine position, and the infant may be swaddled in a blanket, or a papoose board may be used to restrain movement. Occasionally, the parents will be more anxious than the child, and the phlebotomist will need to make the decision to request help from a colleague phlebotomist to properly and safely perform the collection.3,4

Laboratory Assessment of Exposure to Neurotoxic Agents

Lawrence K. Oliver, in Clinical Neurotoxicology, 2009

SPECIMEN COLLECTION

The phlebotomist assigned to collect blood, plasma, or serum for analysis of toxins must be especially careful to avoid contamination of the draw site. Special metal-free collection equipment and vials must be used when collecting blood for analysis for screening for environmental metal toxins. Contamination of the collection site can be avoided with careful cleaning with an alcohol swab. Iodine-containing disinfectants are to be avoided. Special metal-free collection tubes must be used for specimen transport. Any commercially available stainless steel needle or butterfly device is acceptable.

Follow the instructions of your laboratory to determine what specimen type to use. In general, ethylenediaminetetraacetic acid (EDTA) is the preferred anticoagulant, primarily because other agents are more likely to give microclotting over time, which can clog instrumentation and make processing difficult.

Urine must be collected into a container that does not use a metal cap for closure and does not have any glued inserts into the cap, since they contain sufficient metals to give falsely elevated results. Do not collect urine in the environment in which exposure is suspected. Never use a colored container for collection because of metal-containing dyes.

Most organic or protein-based neurotoxins are present in low levels in biological fluids, often have a short half-life, and are only marginally stable at ambient temperatures. It is highly recommended to keep a chart handy that outlines the specimen handling requirements for your laboratory so that time is not wasted in specimen collection or the sample is not compromised by delays after it is removed from the body.

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B978032305260350023X

Bedside Laboratory and Microbiologic Procedures

James R. Roberts MD, FACEP, FAAEM, FACMT, in Roberts and Hedges’ Clinical Procedures in Emergency Medicine and Acute Care, 2019

Technique for Obtaining Blood for Culture

False-positive blood cultures obtained in the ED can result in up to $8800 in additional costs, with an average increase in hospital length of stay of 1 day per patient.145 Studies have demonstrated sources of contamination at every stage of the process of performing and processing blood cultures. In addition to obvious sources of contamination from the patient's and phlebotomist's skin, antiseptic agents and gloves have been implicated.146,147 Some authorities have argued that the primary source of contamination is in the laboratory processing of specimens.148 The consensus is that the most common source of contamination is the process of phlebotomy and inoculation of blood culture bottles.145,149,150 Obviously, this is the single step over which emergency clinicians have control, either directly or via protocols of technique for blood culture phlebotomy. Contamination rates are typically between 1.5% and 3%,128,151,152 although many ED series show much higher rates.139,145,153 Conversely, settings in which there are rigorous protocols for obtaining blood cultures have contamination rates as low as 1%.150

A high degree of sensitivity is required for blood cultures. Many significant bacteremic illnesses have been documented with as little as 1 CFU/10 mL of blood.154,155 In a cadaver study, human skin has been shown to have a bacterial concentration of between 103 and 106 CFUs/mL on the forearm and groin, respectively.156 Designed to detect vanishingly low concentrations of bacteria, the test is clearly susceptible to false-positive results (impaired specificity) when blood must necessarily be obtained by passing a needle through the skin. Eighty percent of the skin flora is transient, superficial, and removable; 20% inhabit the sebaceous ducts and hair follicles and cannot be removed without destroying the skin.156,157 The former group consists of predominantly gram-positive and gram-negative aerobes and is the target of skin disinfectants.

The primary agents for skin disinfection are iodine compounds, alcohols, chlorhexidine, and hexachlorophene. Iodine solution remains a gold standard and kills bacteria, fungi, protozoa, and viruses but has been replaced in many institutions because of concern about skin burns and allergic reactions. Reports of the former were probably due to the use of 7% solution. The risk for a burn or an allergic reaction is thought to be negligible with the currently available 2% preparation.149 The most effective cleansing agent is tincture of iodine, which is a mixture of 2% iodine solution and 70% alcohol.158,159 Povidone-iodine 10% solution (Betadine, Purdue Pharma L.P., Stamford, CT) has a much lower free-iodine concentration than iodine solution and is therefore less potent. Iodine is superior to hexachlorophene and chlorhexidine in killing gram-negative bacteria. Iodine, like other antiseptic agents, is inhibited by the presence of organic matter and thus requires thorough skin cleansing before the application of any skin disinfectant.

Blood Donation and Collection

Shanna Morgan, Salima Shaikh, in Transfusion Medicine, Apheresis, and Hemostasis, 2018

The phlebotomist identifies an appropriate venipuncture site and scrubs the area thoroughly with disinfectant. A blood sample for platelet count is obtained and the donor is placed on the apheresis instrument. The sample diversion pouch fills with blood and the donor’s blood volume circulates throughout the instrument. Midway through the procedure, the donor experiences perioral tingling, nausea, and muscle cramping. The collection staff performs therapeutic interventions according to the standard operating procedures (SOPs) and the procedure continues. The remainder of the collection proceeds without incident. The final product is approximately 300 mL of platelets suspended in plasma.

32.

What is the purpose of the sample diversion pouch mentioned in this case?

A.

The antecubital skin plug is drawn into the sample diversion pouch, to prevent bacterial contamination of the collected product

B.

Blood samples for hemoglobin testing are drawn from the sample diversion pouch

C.

The blood in the sample diversion pouch is added to the collected product, for transfusion

D.

The blood in the sample diversion pouch is stored only for use in adverse event investigation

E.

The blood in the sample diversion pouch is not used for any purpose and is simply discarded

Concept: During blood donation, the first 40–50 mL of blood goes into what is called a diversion pouch. This has proven to be highly effective in reducing bacterial contamination of blood products.

Answer: A—The phlebotomist thoroughly disinfects the donor’s antecubital areas to prevent skin contaminant microorganisms (usually gram positive cocci such as Staphylococcus or Streptococcus) from entering the collected blood product after venipuncture. However, the needle also comes into contact with a skin plug underneath the donor’s skin during venipuncture. This skin plug is not accessible to the arm scrub and may carry skin flora, which could contaminate the collected blood product unless it is diverted into another bag with the first 40–50 mL of the initial blood draw. The sample diversion pouch is used for this purpose. Integration of this method has significantly reduced the risk of bacterial contamination. The greatest reduction in rate of bacterial contamination is seen with platelet products, which are prone to contamination as they are stored at room temperature in which Gram positive cocci grow easily. Samples for infectious disease testing are also drawn from the sample diversion pouch, but it is not used in adverse event testing or for testing the donor’s hemoglobin level (Answers B and D), nor is it simply discarded without any further use (Answer E). Blood in the pouch should never be used for transfusion (Answer C).

33.

This donor’s pre-donation platelet count result is 170,000/μL. Which statement about platelet counts for apheresis platelet donors is correct?

A.

A blood sample should be collected 2 weeks prior to each plateletpheresis procedure to determine the donor’s platelet count

B.

The predonation platelet count result is not necessary to qualify the donor for a same day platelet apheresis donation

C.

Platelet count results performed prior to or after the procedure may not be used to qualify the donor for the next procedure

D.

Based on this donor’s predonation platelet count, he is not eligible to donate platelets

E.

A triple platelet apheresis product can be drawn from a first time platelet donor, if certain requirements are met

Concept: To ensure a quality product and donor safety, donors of apheresis platelets have additional criteria to meet before being allowed to donate.

Answer: B—According to the current edition of AABB Standards for Blood Banks and Transfusion Services (30th edition, 2016), a donor is deferred if the platelet count is less than 150,000 u/L, until the platelet count is measured to be greater than or equal to 150,000 u/L. Therefore, this donor is eligible to donate platelets today (Answer D). The platelet count can be performed prior to or after the collection procedure as the guidelines do not specify the timeframe for when the blood sample has to be drawn (Answer A). Since this person is a repeat donor, the results can be used to qualify the donor for the next platelet donation (Answer C). First time platelet donors should be tested prior to the first donation whenever possible. A triple platelet apheresis product should not be collected from a first time platelet donor, but can be drawn from repeat platelet donors if the donor’s platelet count meets certain thresholds, depending on the apheresis instrument used (Answer E).

34.

What types of interventions did the collections staff person most likely perform, once the donor started experiencing symptoms (perioral tingling, nausea, and muscle cramping) during the collection procedure?

A.

Slow down the calcium infusion rate and administer citrate to the donor

B.

Increase the citrate infusion rate

C.

Continue the procedure without citrate infusion

D.

Slow down the citrate infusion rate and administer oral or intravenous calcium to the donor

E.

Call a neurologist to assess the donor’s symptoms

Concept: Citrate is an effective anticoagulant for apheresis procedures. It works by binding calcium in the blood, which is necessary for a critical step in the coagulation cascade. If too much citrate reenters the body, especially in patients with poor liver or renal function, the citrate will cause hypocalcemia in the donor.

Answer: D—The donor’s symptoms of perioral tingling, nausea, and muscle cramping is most consistent with a hypocalcemia reaction to the citrate anticoagulant in the apheresis device. Citrate chelates calcium, and to a lesser extent magnesium, in order to prevent clotting of blood within the apheresis instrument and stored blood products. Because citrate is used in the instrument, the donor becomes exposed when the donor’s blood is returned from the device. This occurs throughout the procedure.

Symptoms of citrate toxicity can include nausea, tingling, cramping, hypotension, decreased pulse pressure, arrhythmias, mental status changes, coagulopathy, twitching, and other symptoms associated with hypocalcemia or hypomagnesemia. Sequela of citrate exposure is dependent upon rate and duration of citrate administration, along with donor size and rate of metabolism. Interventions may include pausing the procedure, slowing down the citrate infusion rate and replacement of calcium, either orally or intravenously. If the donor’s symptoms continue or increase in severity, call the blood donor center medical director, who will decide whether to stop the procedure. None of the other interventions are appropriate for treating citrate toxicity (Answers A, B, C, and E).

35.

The donor wants to return for another platelet donation tomorrow. Which of the following represents the correct response to his request?

A.

No, he cannot return tomorrow for another platelet donation. Plateletpheresis can be performed once per week, not to exceed 24 times in a rolling 12 month period. The interval between procedures should be at least 3 days.

B.

No, he cannot return tomorrow for another platelet donation. Plateletpheresis can be performed once a month, not to exceed 12 times in a rolling 12 month period. The interval between procedures should be at least 2 days.

C.

No, he cannot return tomorrow for another platelet donation. Plateletpheresis can be performed twice in a 7 day period, not to exceed 24 times in a rolling 12 month period. The interval between procedures should be at least 2 days.

D.

Yes, he can return tomorrow for another platelet donation. Unlike red blood cells, platelets can be donated at any time as long as the donor’s platelet count is greater than 150,000 u/L.

E.

Yes, he can return tomorrow for another platelet donation. He is no longer symptomatic from his reaction so he is eligible to donate platelets again.

Concept: To promote donor safety and product quality, platelet donors can only present for donation as specified intervals.

Answer: C—According to the current edition of AABB Standards for Blood Banks and Transfusion Services (29th edition, 2014), a platelet apheresis donor can be collected a maximum of 2 times in a 7 day period, not to exceed 24 times in a rolling 12 month period. The interval between the two collections should be at least 2 days. These guidelines are mandated by Food and Drug Administration (FDA) guidance’s for industry to prevent excessive donor platelet and plasma loss. Blood centers will defer a donor once they have reached these limits, until they are eligible again to donate. In unusual circumstances, the blood center medical director can make an exception to allow a donor to donate platelets outside of these guidelines. Based on the criteria discussed above, all the other choices (Answers A, B, D, and E) are incorrect.

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9780128039991000043

Blood Donation

Mary Townsend MD, Salima Shaikh MD, in Transfusion Medicine and Hemostasis (Third Edition), 2019

Phlebotomy

Blood must be collected by a trained phlebotomist using aseptic methods, and a sterile, closed system. The blood unit should be collected from a suitable vein in a single venipuncture after the pressure device (blood pressure cuff or tourniquet) has been deflated and reinflated. WB is collected into a closed blood collection set consisting of a sterile collection bag containing anticoagulant (typically 70 mL of anticoagulant in a container approved to collect 500 ± 50 mL of WB), integrally attached tubing, and a large bore needle.

The total amount collected from the donor, including segments and specimen tubes, should not exceed 10.5 mL/kg of donor weight. During collection, blood should be thoroughly mixed with anticoagulant to prevent clotting, either manually or automatically.

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9780128137260000052

Blood Donor, Donation Process and Technical Aspects of Blood Collection

Debra A. Kessler RN, MS, in Transfusion Medicine and Hemostasis (Second Edition), 2013

Phlebotomy

Blood must be collected by a trained phlebotomist using aseptic methods, and a sterile, closed system. The blood unit should be collected from a suitable vein in a single venipuncture, within the antecubital fossa of the donor’s arm, after the pressure device (blood pressure cuff or tourniquet) has been deflated and re-inflated. Whole blood is collected into a closed blood collection set consisting of a sterile collection bag containing anticoagulant (typically 70 ml of anticoagulant is in a container to collect 500 ml ± 50 ml of whole blood), integrally attached tubing, and a large bore needle.

The total amount collected from the donor, including segments and specimen tubes, should not exceed 10.5 ml/kg of donor weight (whole blood collections). During collection, the blood should be mixed well with the anticoagulant in the bag to prevent clotting. Some blood centers use staff to agitate the bag from side to side to mix the fresh blood with anticoagulant; others utilize a specialized shaker device to mix the blood and anticoagulant mechanically.

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9780123971647000057

Collection and Handling of Blood

Christopher McNamara, in Dacie and Lewis Practical Haematology (Twelfth Edition), 2017

Phlebotomy procedure

Staff undertaking this procedure should be adequately trained. The phlebotomist must check that the patient’s identity corresponds to the details on the request form and also ensure that the phlebotomy tray contains all the required specimen containers and other equipment necessary for the procedure.

A tourniquet should be applied just above the intended venepuncture site. Blood is best withdrawn from an antecubital vein or other visible veins of the forearm by means of either an evacuated tube or a syringe. It is recommended that the skin be cleaned with 70% alcohol (e.g., isopropanol) and allowed to dry spontaneously before being punctured. The tourniquet should be released as soon as the vein is punctured and blood begins to flow into the syringe or evacuated tube – delay in releasing the tourniquet leads to fluid shift and haemoconcentration as a result of venous blood stagnation.6 After the vein has been successfully punctured, the piston of the syringe should be withdrawn slowly with no attempt being made to withdraw blood faster than the vein is filling. Anticoagulated specimens must be mixed by inverting the container several times. The risk of unwanted haemolysis of the specimen can be minimised by using minimal tourniquet time, withdrawing blood carefully, using an appropriately sized needle, delivering the blood slowly into the receptacle and avoiding unnecessary agitation when mixing with the anticoagulant. Note that if blood is drawn too slowly or is inadequately mixed with the anticoagulant some coagulation may occur, rendering the sample unsuitable. After collection, containers must be firmly capped to minimise the risk of leakage.

If blood collection fails, it is important to remain calm, communicate with the patient and consider the possible causes. These include poor technique (e.g., passing the needle through the vein, or poor selection of veins), scarring of tissues and haematoma formation.

After obtaining the necessary specimens, remove the needle and press a sterile swab over the puncture site. Gentle pressure should be applied to the swab with the arm slightly elevated for a minute before checking that bleeding has completely ceased. Finally, the puncture site should be covered with a small adhesive dressing.

Obtaining blood from an indwelling line or catheter is an important potential source of error. It is common practice to flush indwelling lines with heparin, so they must be flushed free from heparin and the first 5 ml of blood must be discarded before any blood is collected for laboratory testing. If intravenous fluids are being transfused into an arm, blood should generally not be collected from that arm; however, if this is essential, the specimen should be obtained from below the intravenous infusion with the tourniquet being placed below the site of infusion.

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9780702066962000011

Variables affecting endocrine tests results, errors prevention and mitigation

Hossein Sadrzadeh PhD, ... Gregory Kline MD, in Endocrine Biomarkers, 2017

1.6.2.3 Arterial blood collection

Collection of a blood specimen from an arterial site is more complicated and requires the phlebotomist have special training to properly perform the technique; otherwise a physician or a nurse should collect the blood specimen from this site. Arterial blood is used only for blood gas analysis including pO2, pCO2, pH, and sometimes lactate. The site of arterial blood collection, in their order of preference, is radial, brachial, and femoral arteries [16]. For neonates, umbilical artery catheter is the best site to collect the blood [16]; however, these sites need to be free of inflammation, infection, or edema.

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B978012803412500001X

Which of the following needle gauges are used for collecting donor units of blood?

In general, use a 16-gauge needle (see Table 3.1 in Chapter 3), which is usually attached to the blood collection bag.

What are the 3 types of phlebotomy needle state their uses?

Phlebotomy Equipment.
Syringe – syringes are used to collect blood from patients with small or fragile veins. ... .
Multi-sample blood collection needle – this device has two needles that are screwed into the holder. ... .
Tourniquet – this device is used to occlude venous blood flow and help phlebotomists discover the vein..

What is the name of the needle used to draw blood?

A butterfly needle is a device used to access a vein for drawing blood or giving medications. Some medical professionals call a butterfly needle a “winged infusion set” or a “scalp vein set.” The set gets its name because there are plastic “wings” on either side of a hollow needle used to access the vein.

What is a 23 gauge needle used for?

The normal medical use for the 23G 25mm (1inch) needle is for Intramuscular, intravenous, and subcutaneous injections.